Free tool
FAERS Monitor: Ziihera
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 761416 or its brand name (Ziihera, Zanidatamab-Hrii). Reports on generic versions are filed under their own applications.
Reports
82
Serious
37
45% of reports
Hospitalization
7
Death reported
8
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use23
- infusion related reaction11
- diarrhoea10
- chills9
- pyrexia6
- ejection fraction decreased4
- hyperpyrexia3
- acute kidney injury2
- arthralgia2
- disease progression2
- drug ineffective2
- gastrointestinal haemorrhage2
- hypersensitivity2
- oxygen saturation decreased2
- platelet count decreased2
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2025 | 35 |
| 2026 | 47 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,077 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hyperpyrexiaSignal | 3 | 181.9 | 59.9 | 374 |
| ejection fraction decreasedSignal | 4 | 66.0 | 25.4 | 195 |
| infusion related reactionSignal | 11 | 42.6 | 24.6 | 407 |
| chillsSignal | 9 | 19.7 | 10.6 | 142 |
| oxygen saturation decreased | 2 | 9.1 | 2.3 | 8 |
| off label useSignal | 23 | 6.7 | 4.8 | 111 |
| gastrointestinal haemorrhage | 2 | 6.1 | 1.6 | 4 |
| platelet count decreased | 2 | 4.8 | 1.2 | 3 |
| pyrexiaSignal | 6 | 4.4 | 2.1 | 13 |
| disease progression | 2 | 4.3 | 1.1 | 2 |
| diarrhoeaSignal | 10 | 4.0 | 2.2 | 20 |
| acute kidney injury | 2 | 3.4 | 0.9 | 1 |
| hypersensitivity | 2 | 2.8 | 0.7 | 1 |
| arthralgia | 2 | 1.2 | 0.3 | 0 |
| drug ineffective | 2 | 0.4 | 0.1 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.